Paul D. Walker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paul D. Walker has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Christopher Bishop
Department of Anatomy & Cell Biology, Wayne State University School of Medicine, 540 East Canfield, Detroit, MI 48201, USA
3 shared publicationsAndranig A Adjemian
Wayne State Univ, Anat Sci, Sch Med, Detroit, MI 48201 USA
1 shared publicationChase W. Morrison
Anatomical Sciences, Wayne State University School of Medicine, Detroit, USA
1 shared publication- Christopher Bishop
Department of Psychology, Binghamton University, Binghamton, NY 13902, USA
1 shared publication - Corinne Y. Ostock
Behavioral Neuroscience Program, Department of Psychology, Binghamton University, 4400 Vestal Parkway East, Binghamton, NY 13902-6000, USA
1 shared publication David M. Krolewski
Department of Anatomy and Cell Biology, Wayne State University, School of Medicine, Detroit, Michigan 48201, USA
1 shared publication
Latest Publications
- Open Access
- 9 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27822
Large Incarcerated Inguinal Hernia: A Case Report
A 90-year-old white male cadaver was found to have an incarcerated left inguinal hernia (IH). Although IHs are a very common pathology, the size and extent of this IH make it a unique case study. Upon gross dissection of the abdominal and pelvic cavities, 79 cm of small and large bowel was removed from the scrotal sac. The extent of the herniation had enlarged the scrotal sac to over 14 cm in both height and width and over 10 cm in depth. The herniation also caused the penis to become buried in the skin and not visible.
- 9 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27822
Open AccessLarge Incarcerated Inguinal Hernia: A Case Report
A 90-year-old white male cadaver was found to have an incarcerated left inguinal hernia (IH). Although IHs are a very common pathology, the size and extent of this IH make it a unique case study. Upon gross dissection of the abdominal and pelvic cavities, 79 cm of small and large bowel was removed from the scrotal sac. The extent of the herniation had enlarged the scrotal sac to over 14 cm in both height and width and over 10 cm in depth. The herniation also caused the penis to become buried in the skin and not visible.
- 1 January 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 138, 305-312
Effects of gender on locomotor sensitivity to amphetamine, body weight, and fat mass in regulator of G protein signaling 9 (RGS9) knockout mice
- 1 January 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 138, 305-312
Effects of gender on locomotor sensitivity to amphetamine, body weight, and fat mass in regulator of G protein signaling 9 (RGS9) knockout mice
- 1 September 2011
- Published by Elsevier in Neuropharmacology
- Vol. 61 (4) , 753-760
Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation
- 1 September 2011
- Published by Elsevier in Neuropharmacology
- Vol. 61 (4) , 753-760
Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation
- 30 September 2005
- Published by Elsevier in Neuropharmacology
- Vol. 49 (3) , 350-358
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958
- 30 September 2005
- Published by Elsevier in Neuropharmacology
- Vol. 49 (3) , 350-358
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958
Intrastriatal dopamine D1 receptor agonist‐mediated motor behavior is reduced by local neurokinin 1 receptor antagonism
Recent evidence suggests that striatal neurokinin receptors modulate dopamine (DA)‐induced motor behaviors. To further examine this, we studied the effects of intrastriatal neurokinin 1 receptor (NK1R) antagonism on motor behaviors induced by direct infusion of the full DA D1 receptor agonist SKF 82958. Adult male Sprague‐Dawley rats received bilateral intrastriatal 0.8‐μl infusions of the NK1R receptor antagonist LY 306,740 (0, 27, or 54 nmol/side) followed by intrastriatal infusions of SKF 82958 (0 or 24 nmol/side) into the dorsal striatum. Following each infusion, rats were placed into automated activity monitors for the quantification of horizontal activity, total distance traveled, movement bouts, and stereotypy counts. As expected, SKF 82958 increased motor activity on all behavioral measures. More importantly, whereas 27 nmol was without effect, prior infusion of 54 nmol LY 306,740 significantly reduced most aspects of behavior. The results of this study suggest that functional NK1Rs within the striatum play a permissive role in the motor behaviors induced by D1R stimulation. Synapse 57:1–7, 2005.
Intrastriatal dopamine D1 receptor agonist‐mediated motor behavior is reduced by local neurokinin 1 receptor antagonism
Recent evidence suggests that striatal neurokinin receptors modulate dopamine (DA)‐induced motor behaviors. To further examine this, we studied the effects of intrastriatal neurokinin 1 receptor (NK1R) antagonism on motor behaviors induced by direct infusion of the full DA D1 receptor agonist SKF 82958. Adult male Sprague‐Dawley rats received bilateral intrastriatal 0.8‐μl infusions of the NK1R receptor antagonist LY 306,740 (0, 27, or 54 nmol/side) followed by intrastriatal infusions of SKF 82958 (0 or 24 nmol/side) into the dorsal striatum. Following each infusion, rats were placed into automated activity monitors for the quantification of horizontal activity, total distance traveled, movement bouts, and stereotypy counts. As expected, SKF 82958 increased motor activity on all behavioral measures. More importantly, whereas 27 nmol was without effect, prior infusion of 54 nmol LY 306,740 significantly reduced most aspects of behavior. The results of this study suggest that functional NK1Rs within the striatum play a permissive role in the motor behaviors induced by D1R stimulation. Synapse 57:1–7, 2005.
Intrastriatal serotonin 5‐HT2 receptors mediate dopamine D1‐induced hyperlocomotion in 6‐hydroxydopamine‐lesioned rats
Striatal dopamine (DA) and serotonin (5‐HT) functions are altered following DA denervation. Previous research indicates that intrastriatal coadministration of D1 and 5‐HT2 receptor agonists synergistically increase locomotor behavior in DA‐depleted rats. In the present study, we examined whether striatal 5‐HT2 mechanisms also account for supersensitive D1‐mediated locomotor behavior following DA denervation. Adult male Sprague‐Dawley rats were subjected to bilateral striatal cannulation and then received either intracerebroventricular (i.c.v.) or intrastriatal 6‐hydroxydopamine (6‐OHDA; 200 μg or 20 μg/side, respectively). After at least 3 weeks, i.c.v.‐lesioned rats received intrastriatal infusions of the 5‐HT2 receptor antagonist ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by systemic SKF 82958, a D1 agonist (1.0 mg/kg, i.p.) and locomotor activity was monitored. In another experiment, intrastriatal sham and 6‐OHDA‐lesioned rats received bilateral intrastriatal infusions of ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by intrastriatal infusions of SKF 82958 (5.0 μg/side) or vehicle (0.9% saline). Rats with DA loss demonstrated supersensitive locomotor responses to both systemic and intrastriatal SKF 82958. Ritanserin pretreatment blunted systemic SKF 82958‐induced hyperlocomotion and returned intrastriatal D1‐mediated hyperactivity to sham lesion levels. The results of this study suggest that striatal 5‐HT2 receptors contribute to D1‐mediated hyperkinesias resulting from DA loss and suggest a pharmacological target for the alleviation of dyskinesia that can develop with continued DA replacement therapy. Synapse 50:164–170, 2003.
Intrastriatal serotonin 5‐HT2 receptors mediate dopamine D1‐induced hyperlocomotion in 6‐hydroxydopamine‐lesioned rats
Striatal dopamine (DA) and serotonin (5‐HT) functions are altered following DA denervation. Previous research indicates that intrastriatal coadministration of D1 and 5‐HT2 receptor agonists synergistically increase locomotor behavior in DA‐depleted rats. In the present study, we examined whether striatal 5‐HT2 mechanisms also account for supersensitive D1‐mediated locomotor behavior following DA denervation. Adult male Sprague‐Dawley rats were subjected to bilateral striatal cannulation and then received either intracerebroventricular (i.c.v.) or intrastriatal 6‐hydroxydopamine (6‐OHDA; 200 μg or 20 μg/side, respectively). After at least 3 weeks, i.c.v.‐lesioned rats received intrastriatal infusions of the 5‐HT2 receptor antagonist ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by systemic SKF 82958, a D1 agonist (1.0 mg/kg, i.p.) and locomotor activity was monitored. In another experiment, intrastriatal sham and 6‐OHDA‐lesioned rats received bilateral intrastriatal infusions of ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by intrastriatal infusions of SKF 82958 (5.0 μg/side) or vehicle (0.9% saline). Rats with DA loss demonstrated supersensitive locomotor responses to both systemic and intrastriatal SKF 82958. Ritanserin pretreatment blunted systemic SKF 82958‐induced hyperlocomotion and returned intrastriatal D1‐mediated hyperactivity to sham lesion levels. The results of this study suggest that striatal 5‐HT2 receptors contribute to D1‐mediated hyperkinesias resulting from DA loss and suggest a pharmacological target for the alleviation of dyskinesia that can develop with continued DA replacement therapy. Synapse 50:164–170, 2003.